Report ID: SQMIU35I2334
Report ID:
SQMIU35I2334 |
Region:
US, Europe, and Brazil |
Published Date: July, 2024
Pages:
165
|
Tables:
50 |
Figures:
74
In 2023, US dominated the market and had the highest revenue share (60.01%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.
It is expected that the U.S. will be the fastest-growing region in the alopecia market, since it grows at the highest CAGR of all. The growth is mainly driven by increasing technological efforts and awareness programs being undertaken by both the government and commercial entities in the country. The other factor is extensive research on alopecia treatments done in the U.S. The outcome aids in better understanding, preventing, and managing the condition that lures investments and innovations in this field. Thus, the U.S. market characterizes the rapid growth in view of the swelling awareness, state-of-the-art technology, and well-funded research programs at almost every front to push it to the limelight of innovations in the treatment of alopecia.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIU35I2334